These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1773423)

  • 21. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of donepezil on verbal memory after semantic processing in healthy older adults.
    FitzGerald DB; Crucian GP; Mielke JB; Shenal BV; Burks D; Womack KB; Ghacibeh G; Drago V; Foster PS; Valenstein E; Heilman KM
    Cogn Behav Neurol; 2008 Jun; 21(2):57-64. PubMed ID: 18541979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selegiline hydrochloride and cognition.
    Lees AJ
    Acta Neurol Scand Suppl; 1991; 136():91-4. PubMed ID: 1801544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tranylcypromine compared with L-deprenyl in Alzheimer's disease.
    Tariot PN; Sunderland T; Cohen RM; Newhouse PA; Mueller EA; Murphy DL
    J Clin Psychopharmacol; 1988 Feb; 8(1):23-7. PubMed ID: 3127432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.
    Neurology; 1998 Mar; 50(3):645-51. PubMed ID: 9521250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.
    Watson GS; Cholerton BA; Reger MA; Baker LD; Plymate SR; Asthana S; Fishel MA; Kulstad JJ; Green PS; Cook DG; Kahn SE; Keeling ML; Craft S
    Am J Geriatr Psychiatry; 2005 Nov; 13(11):950-8. PubMed ID: 16286438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lexical-semantic treatment on memory in early Alzheimer disease: an observer-blinded randomized controlled trial.
    Jelcic N; Cagnin A; Meneghello F; Turolla A; Ermani M; Dam M
    Neurorehabil Neural Repair; 2012 Oct; 26(8):949-56. PubMed ID: 22460609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential responsivity of verbal and visual recognition memory to physostigmine and ACTH.
    Rose RP; Moulthrop MA
    Biol Psychiatry; 1986 May; 21(5-6):538-42. PubMed ID: 3008865
    [No Abstract]   [Full Text] [Related]  

  • 30. Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia.
    Campi N; Todeschini GP; Scarzella L
    Clin Ther; 1990; 12(4):306-14. PubMed ID: 2121359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective effects of cholinergic treatment on verbal memory in posttraumatic amnesia.
    Goldberg E; Gerstman LJ; Mattis S; Hughes JE; Sirio CA; Bilder RM
    J Clin Neuropsychol; 1982 Sep; 4(3):219-34. PubMed ID: 7142421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rey-Auditory Verbal Learning and Rey-Osterrieth Complex Figure Design performance in Alzheimer's disease and closed head injury.
    Bigler ED; Rosa L; Schultz F; Hall S; Harris J
    J Clin Psychol; 1989 Mar; 45(2):277-80. PubMed ID: 2723084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems.
    Bolívar JC; Saladie DG
    J Alzheimers Dis; 2016 May; 53(2):705-12. PubMed ID: 27163821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases.
    Knoll J
    J Neural Transm Suppl; 1993; 40():69-91. PubMed ID: 8294902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some aspects of memory disorders clearly distinguish dementia of the Alzheimer's type from depressive pseudo-dementia.
    Gainotti G; Marra C
    J Clin Exp Neuropsychol; 1994 Feb; 16(1):65-78. PubMed ID: 8150890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.
    Rondanelli M; Opizzi A; Faliva M; Mozzoni M; Antoniello N; Cazzola R; Savarè R; Cerutti R; Grossi E; Cestaro B
    Nutr Neurosci; 2012 Mar; 15(2):46-54. PubMed ID: 22334085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI).
    Ferris S; Schneider L; Farmer M; Kay G; Crook T
    Int J Geriatr Psychiatry; 2007 May; 22(5):448-55. PubMed ID: 17117395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (-)Deprenyl-medication: a strategy to modulate the age-related decline of the striatal dopaminergic system.
    Knoll J
    J Am Geriatr Soc; 1992 Aug; 40(8):839-47. PubMed ID: 1634730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition memory span in mildly and moderately demented patients with Alzheimer's disease.
    Salmon DP; Granholm E; McCullough D; Butters N; Grant I
    J Clin Exp Neuropsychol; 1989 Aug; 11(4):429-43. PubMed ID: 2760179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memory integration in amnesia: prior knowledge supports verbal short-term memory.
    Race E; Palombo DJ; Cadden M; Burke K; Verfaellie M
    Neuropsychologia; 2015 Apr; 70():272-80. PubMed ID: 25752585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.